<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6724274\results\search\drugs\results.xml">
  <result pre="(sweat chloride concentration ≥ 60 mmol/L) and/or two CFTR gene mutations. None received" exact="palivizumab" post="because it is not used in our current practice."/>
  <result pre="immediate family environment. Half attended exclusively family daycare. None received" exact="palivizumab" post="and 22 patients (88%) were vaccinated against influenza virus."/>
  <result pre="palivizumab-free. The American Academy of Pediatrics recommends the use of" exact="palivizumab" post="in CF for targeted patients, particularly those with poor"/>
  <result pre="D, American Academy of Pediatrics Bronchiolitis Guidelines CUpdated guidance for" exact="palivizumab" post="prophylaxis among infants and young children at increased risk"/>
 </snippets>
</snippetsTree>
